Gut Microbiota and Trichoscopic Changes in Women With Telogen Effluvium on a Multifactorial Drinkable Nutraceutical: A Retrospective Observational Study
Gut Dysbiosis in Premenopausal Women With Telogen Effluvium, Baseline Characterization and 6-Month Trichoscopic Outcomes With a Multifactorial Drinkable Nutraceutical: A Retrospective Observational Study
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Not yet recruiting
- Declared phase
- No phase declared
- Sponsor
- Olistic Research Labs S.L.
- Participants (registry)
- 30
- Start
- October 2026 (planned)
- Primary completion
- December 2026 (planned)
- Study completion
- February 2027 (planned)
- Last registry update
- October 2026
- Countries
- Spain
Conditions studied: Gut Dysbiosis, Telogen Effluvium, Hair Loss
Interventions: Drinkable multifactorial food supplement containing vitamins, minerals, plant extracts, and other bioactive compounds, formulated to support hair growth and scalp health in women.
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.